Speaker Profile
Ph.D., Executive Director, External Strategy and Partnerships, Buck Inst.
Biography
Yi Sherry Zhang is a genomics scientist and health-tech entrepreneur advancing the translation of longevity science into scalable population impact. At the Buck Institute for Research on Aging, she leads the development of Healthspan Horizons, a federated AI and biodata platform integrating multi-omics, digital, and clinical signals to quantify and extend healthy human lifespan. Drawing on nearly two decades of experience at the intersection of molecular science, data intelligence, and personalized health, she previously founded Geno Palate, which built one of the worlds largest nutrigenomics databases and consumer platforms for precision nutrition. Her work bridges molecular biomarkers and actionable lifestyle insights, with publications and features spanning scientific and public domains. An advocate for equitable access to scientific wellness, she speaks globally on data federation, precision aging, and the future of healthspan intelligence.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair:
Michael Goldman, SFSU
PMWC Award Ceremony
• David Sinclair, Harvard
• Steve Horvath, Altos Labs
• Nir Barzilai, Albert Einstein College of Medicine
AI-Driven Biomarkers to Quantify Aging
• Chair: Alex Zhavoronkov, Insilico Medicine
• Mahdi Moqri, Harvard
• Steve Horvath, Altos Labs
• Hussain Ahamed, Ultrahuman
Epigenetic Aging Signatures in Large Human Cohorts
• Varun Dwaraka, TruDiagnostic
AI Systems for Personalized Longevity: How Biomarkers Translate into Actionable Interventions
• Chair: Nathan Price, Buck Institute
• Sherry Zhang, Buck Institute
• Ranjan Sinha, Digbi Health
• Zeenia Framroze, Alethios, Inc.
• John Ramunas, Rejuvenation Technologies
Clinical Trial Design & Functional Endpoints for Healthspan
• Nir Barzilai, Albert Einstein College of Mediciney
The data We Need For AI To Accelerate Longevity Drugs
• Martin Jensen, Gordian Biotechnology
From Genome to an AI-Drive Longevity Platform
• Wei-Wu He, Human Longevity
Wellness Wearables: The Journey to Clinical
• Hussain Ahamed, Ultrahuman
Longevity Medicine: Ambition vs Evidence in the Era of Precision Health
• Aubrey de Grey, LEV Foundation
Precision Aging & Longevity Focused on Limited Lifespan Evidence, Vanishing Blue Zones, and Payer ROI
• S. Jay Olshansky, University of Illinois
Evolutionary perspectives on human lifespan and healthspan
• Michael Gurven, UC Santa Barbara
